Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 7/20 | 0.53 |
| ▸ | ANPEP | P15144 | 6/20 | 0.53 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | USP8 | P40818 | 1/20 | 0.34 |
| ▸ | USP7 | Q93009 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | BRD1 | O95696 | 1/20 | 0.31 |
| ▸ | TAF1 | P21675 | 1/20 | 0.31 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17531036 | 0.96 | DPP4 (0.54) | DPP4ANPEPNR1H2NR1H3USP8 | |
| SCHEMBL24383852 | 0.92 | ANPEP (0.46) | DPP4ANPEPNR1H2NR1H3 | |
| SCHEMBL17531023 | 0.90 | ANPEP (0.52) | DPP4ANPEPNR1H2NR1H3USP8 | |
| SCHEMBL17531018 | 0.84 | ANPEP (0.50) | DPP4ANPEPNR1H2NR1H3USP8 | |
| SCHEMBL17531015 | 0.83 | ANPEP (0.49) | DPP4ANPEPNR1H2NR1H3USP8 | |
| SCHEMBL11017362 | 0.83 | DPP4 (0.64) | DPP4ANPEPNR1H2NR1H3FAAH | |
| SCHEMBL17531029 | 0.81 | DPP4 (0.54) | DPP4ANPEPNR1H2NR1H3FAAH | |
| SCHEMBL18105782 | 0.81 | DPP4 (0.42) | DPP4ANPEPNR1H2NR1H3USP8 | |
| SCHEMBL17531251 | 0.80 | DPP4 (0.57) | DPP4ANPEPNR1H2NR1H3 | |
| SCHEMBL127167 | 0.80 | DPP4 (0.57) | DPP4ANPEPNR1H2NR1H3BRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | BASF SE (DE) | 2019-10-22 | — | — | US | disclosed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | BASF SE (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170237005-A1 | PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| WO-2016027217-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | BASF SE (DE) | 2016-02-25 | — | — | WO | disclosed |
| WO-2016027218-A1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2016-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | CRY1, NEFM, OR10J3 | DPP4 4308/4885ANPEP 4310/4885NR1H2 3118/4885 |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | CRY1, NEFM, OR10J3 | DPP4 4308/4885ANPEP 4310/4885NR1H2 3118/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | DPP4 2481/4885ANPEP 3850/4885NR1H2 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.